Hi, what are you looking for?
“Bloomberg” has raised the possibility that Israel Chemicals Ltd. (TASE: ICL) could take advantage of its imminent public offering on the New York...
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
– Pharmaceutical company Perrigo has yet to be sold and already major business publications are speculating on what its sale will mean to the TASE....
– The company is responsible for 10% of the trading turnover on the Tel Aviv 25 Index. /By Gali Weinreb and Tali Tsipori/ ...
– The pharmaceutical firm is seeking a merger at a good premium on its $20 billion market cap. – Sources inform “Globes” that pharmaceutical...
– – Last year, Rami Levy joined BTI, the group of businesspeople that supports peace with the Palestinians for the sake of the economy....
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...